Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4639 reports available
All reports
Page 108 of 190
Investing in China: Steadier Ties Stronger Fundamentals
UBS · May 28, 2026
Gold Can Regain Momentum as Tightening Fears Fade
UBS · May 28, 2026
After the Energy Shock
FTSE Russell · May 28, 2026
Leading Index Bulletin
Westpac Banking Corporation · May 28, 2026
Emerging Market Equities Brazil Downgrade
UBS · May 28, 2026
How Major Sport Events Drive Consumer Sectors
UBS · May 28, 2026
Gold Can Regain Momentum as Tightening Fears Fade
UBS · May 28, 2026
Trade of the Week Allianz
UBS · May 28, 2026
US Morning Call
Goldman Sachs · May 28, 2026
Life Healthcare Group 1H26 First Take
Goldman Sachs · May 28, 2026
Dick's Sporting Goods 1Q26 Results First Take
Goldman Sachs · May 28, 2026
China Smartphones April Shipments and Camera Trends
Goldman Sachs · May 28, 2026
China Resources Beer NDR Highlights
Goldman Sachs · May 28, 2026
ASCO 2026 Preview for China Pharma and Biotech Takeaways from Abstracts
Goldman Sachs · May 28, 2026
Brazil Banks April SCR Data Analysis
Goldman Sachs · May 28, 2026
AI On Steroids
The Market Ear · May 28, 2026
Kuaishou Technology 1Q26 Earnings Review
Goldman Sachs · May 28, 2026
European Morning Research Summary
Barclays · May 28, 2026
Key Takeaways From Netherlands Roadshow
Goldman Sachs · May 28, 2026
TMT Special Sales: Snowflake, Salesforce, Capgemini, and ASML Market Update
Goldman Sachs International · May 28, 2026
Inside Commodities
London Stock Exchange Group (LSEG) · May 28, 2026
MiniMed Group Previewing 4QFY26 and FY27 Guidance
Goldman Sachs · May 28, 2026
Par Pacific Holdings Takeaways from Virtual Meeting
Goldman Sachs · May 28, 2026
Pfizer Sig Vedotin Trial Protocol Amendment
Goldman Sachs · May 28, 2026